ATXS icon

Astria Therapeutics
ATXS

Overview Fund Activity

24 hedge funds and large institutions have $10.4M invested in Astria Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
7
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$271K
2
ARTA
2
A.R.T. Advisors
New York
$157K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$161K
4
PAM
4
Panagora Asset Management
Massachusetts
$48K
5
OC
5
Oppenheimer & Co
New York
$169K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$337K
2
BCM
2
Bridgeway Capital Management
Texas
$0
3
SFM
3
Sphera Funds Management
Israel
$409K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
– – -19,106 Closed
Bank of America
27
Bank of America
North Carolina
– – -1,000 Closed
UBS Group
28
UBS Group
Switzerland
$0 323 +323 New
1
2